medigraphic.com
Órgano Oficial de la Asociación Mexicana de Hepatología

2017, Number 3

<< Back Next >>

Ann Hepatol 2017; 16 (3)

What is Changing in Indications and Treatment of Focal Nodular Hyperplasia of the Liver. Is There any Place for Surgery?

Perrakis A, Vassos N, Grützmann R, Croner RS

Language: English
References: 50
Page: 333-341
PDF size: 158.44 Kb.


ABSTRACT

Focal nodular hyperplasia (FNH) is a common benign liver tumor, which occurs in the vast majority of the cases in young women. FNH represents a polyclonal lesion characterized by local vascular abnormalities and is a truly benign lesion without any potential for malignant transformation. A retrospective single institution analysis of 227 FNH patients, treated from 1990 to 2016 and a review of studies reporting surgical therapy of overall 293 patients with FNH was performed. Indications for resection with a focus on diagnostic workup, patient selection, surgical mode and operative mortality and morbidity have been analysed. Ninety three patients underwent elective hepatectomy and 134 patients observation alone, where median follow-up was 107 months. Postoperative complications were recorded in 14 patients, 92% of patients reported an improvement with respect to their symptoms. Overall among 293 patients underwent surgery in the series, included to this review, there was a morbidity of 13%, where median follow-up was 53 months. Systematic follow-up remains the gold standard in asymptomatic patients with FNH. However elective surgery should be considered in symptomatic patients, in those with marked enlargement and in case of uncertainty of diagnosis. Surgery for FNH is a safe procedure with low morbidity and very good long term results as far as quality of life after surgery is concerned and surely an integral part of the modern management of FNH.


REFERENCES

  1. Cherqui D, Rahmouni A, Charlotte F, Boulahdour H, Métreau JM, Meignan M, Fagniez PL, et al. Management of the focal nodular hyperplasia and hepatocellular adenoma in young women: a series of 41 patients with clinical, radiological and pathological correlations. Hepatology 1995; 22: 1674-81.

  2. Bonney GK, Gomez D, Al-Mukhtar A, Toogood GJ, Lodge JP, Prasad R. Indication for treatment and long term outcome of focal nodular hyperplasia. HPB 2007; 9; 368-72.

  3. Herman P, Pugliese V, Machado MA, Montagnini AL, Salem MZ, Bacchella T, D'Albuquerque LA, et al. Hepatic Adenoma and Focal Nodular Hyperplasia: Differential Diagnosis and Treatment. World J Surg 2000; 24; 372-6.

  4. Mathieu D, Kobeiter H, Maison P, Rahmouni A, Cherqui D, Zafrani ES, Dhumeaux D. Oral contraceptive use and focal nodular hyperplasia of the liver. Gastroenterology 2000; 119: 560-4.

  5. Chen MF. Hepatic resection for benign tumors of the liver. J Gastroenterol Hepatol 2000; 15: 587-92.

  6. Belghiti J, Pateron D, Panis Y, Vilgrain V, Fléjou JF, Benhamou JP, Fékété F. Resection of presumed benign liver tumors. Br J Surg 1993; 80: 380-3.

  7. Terkivatan T, de Wilt JHW, de Man RA, van Rijn RR, Zondervan PE, Tilanus HW, IJzermans JN. Indications and long-term outcome of treatment for benign hepatic tumors. Arch Surg 2001; 136: 1033-8.

  8. Hsee LC, McCall JL, Koea JB. Focal nodular hyperplasia: what are the indications for resection? HPB 2005; 7: 298- 302.

  9. Shen YH, Fan J, Wu ZQ, Ma ZC, Zhou XD, Zhou J, Qiu SJ, et al. Focal nodular hyperplasia of the liver in 86 patients. Hepatobiliary Pancreat Dis Int 2005; 6: 52-7.

  10. Descottes B, Glineur D, Lachachi F, Valleix D, Paineau J, Hamy A, Morino M, et al. Laparoscopic liver resection of benign liver tumours. Surg Endosc 2003; 17: 23-30.

  11. Kamphues C, Engel S, Denecke T, Bova R, Hippler-Benscheidt M, Puhl G, Neuhaus P, et al. Safety of liver resection and effect on quality of life in patients with benign hepatic disease: single centre experience. BMC Surg 2011; 11: 16.

  12. Petri A, Hohn J, Kokai EL, Savanya GK, Lázár G. Surgery of benign liver tumours: indications for treatment: twenty years' experience. Hepatogastroenterology 2008; 55: 592-5.

  13. Dietrich CF, Schuessler G, Trojan J, Fellbaum C, Ignee A. Differentiation of focal nodular hyperplasia and hepatocellular adenoma by contrast-enhanced ultrasound. Br J Radiol 2005; 78: 704-7.

  14. Finley AC, Hosey JR, Noone TC, Shackelford DM, Varadarajulu S. Multiple focal nodular hyperplasia syndrome: diagnosis with dynamic, gadolinium-enhanced MRI. Magn Reson Imaging 2005; 23: 511-3.

  15. Grazioli L, Morana G, Kirchin MA, Schneider G. Accurate differentiation of focal nodular hyperplasia from hepatic adenoma at gadobenate dimeglumine-enhanced MR Imaging: Prospective Study. Radiology 2005; 236: 166-77.

  16. Grazioli L, Bondioni MP, Haradome H, Motosugi U, Tinti R, Frittoli B, Gambarini S, et al. Hepatocellular adenoma and focal nodular hyperplasia: value of gadoxetic acid-enhanced MR imaging in differential diagnosis. Radiology 2012; 262: 520-9.

  17. Reddy KR, Kligerman S, Levi J, Livingstone A, Molina E, Franceschi D, Badalamenti S, et al. Benign and solid tumors of the liver: relationship to sex, age, size of tumors and outcome. Am Surg 2001; 67: 173-8.

  18. Fioole B, Kokke M, Van Hillegersberg R, Rinkes IH. Adequate symptom relief justifies hepatic resection for benign disease. BMC Surg 2005; 1: 5-7.

  19. Maillete de Buy Wenniger L, Terpstra V, Beuers U. Focal nodular hyperplasia and hepatic adenoma: epidemiology and pathology. Dig Surg 2010; 27: 24-31.

  20. Dagradi AD, Mangiante GL. Focal nodular hyperplasia of the liver: a single institution experience. Acta Chir Aust 1994; 26: 109.

  21. Nagorney DM. Benign hepatic tumors: focal nodular hyperplasia and hepatocellular adenoma. World J Surg 1995; 19: 13.

  22. Lizardi-Cervera J, Cuéllar-Gamboa L, Motola-Kuba D. Focal nodular hyperplasia and hepatic adenoma: a review. Ann Hepatol 2006; 5: 206-11.

  23. Nahm CB, Ng K, Lockie P, Samra JS, Hugh TJ. Focal nodular hyperplasia - a review of myths and truths. J Gastrointest Surg 2011; 15: 2275-83.

  24. Ehrl D, Rothaug K, Herzog P, Hofer B, Rau HG. "Incidentaloma" of the liver: management of a diagnostic and therapeutic dilemma. HPB Surg 2012; 2012: 891787.

  25. Koea JB. Hepatic incidentaloma: the rule of tens. HPB 2013; 15: 379-83.

  26. Chiche L, Adam JP. Diagnosis and management of benign liver tumors. Semin Liver Dis 2013; 33: 236-47.

  27. Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, et al. Changes in the management of benign liver tumours: an analysis of 285 patients. HPB 2013; 15: 156-63.

  28. Venkatesh SK, Chandan V, Roberts LR. Liver masses: a clinical, radiologic, and pathologic perspective. Clin Gastroenterol Hepatol 2014; 12: 1414-29.

  29. Assy N, Nasser G, Djibre A, Beniashvili Z, Elias S, Zidan J. Characteristics of common solid liver lesions and recommendations for diagnostic workup. World J Gastroenterol 2009; 15: 3217-27.

  30. Navarro AP, Gomez D, Lamb CM, Brooks A, Cameron IC. Focal nodular hyperplasia: a review of current indications for and outcomes of hepatic resection. HPB 2014; 16: 503-11.

  31. Perrakis A, Müller V, Oeckl K, Adamietz B, Demir R, Hohenberger W, Yedibela S. ?ndications and long-term outcome after elective surgery for hepatocellular adenoma. Am Surg 2012; 78: 80-5.

  32. Perrakis A, Demir R, Müller V, Mulsow J, Aydin Ü, Alibek S, Hohenberger W, et al. Management of the focal nodular hyperplasia of the liver. Evaluation of the surgical treatment comparing with observation only. Am J Surg 2012; 204: 689-96.

  33. Yedibela S, Alibek S, Müller V, Aydin U, Langheinrich M, Lohmüller C, Hohenberger W, et al. Management of hemangioma of the liver: surgical therapy or observation? World J Surg 2013; 37: 1303-2.

  34. Strasberg SM. Nomenclature of hepatic anatomy and resections: a review of the Brisbane 2000 system. J Hepatobiliary Pancreat Surg 2005; 12: 351-5.

  35. Available at: http://www.euroqol.org/

  36. Suri C, Jones PF, Patan S, Bartunkova S, Maisonpierre PC, Davis S, Sato TN, et al. Requisite role of angiopoietin-1, a ligand for the TIE2-receptor during embryonic angiogenesis. Cell 1996; 87: 1171-80.

  37. Ijichi H, Taketomi A, Yoshizumi T, Uchiyama H, Yonemura Y, Soejima Y, Shimada M, et al. Hyperbaric oxygen induces vascular endothelial growth factor and reduces liver injury in regenerating rat liver after partial hepatectomy. J Hepatol 2006; 45: 28-34.

  38. Becker YT, Raiford DS, Webb L, Wright JK, Chapman WC, Pinson CW. Rupture and hemorrhage of hepatic nodular hyperplasia. Am Surg 1995; 61: 210-4.

  39. Kleespies A, Settmacher U, Neuhaus P. Spontanruptur einer fokal nodulären Hyperplasie der Leber. Zentralbl Chir 2002; 127: 326-8.

  40. Paradis V, Benzekri A, Dargčre D, Bičche I, Laurendeau I, Vilgrain V, Belghiti J, et al. Telangiectatic focal nodular hyperplasia: a variant of hepatocellular adenoma. Gastroenterology 2004; 126: 1323-9.

  41. Amesur N, Hammond JS, Zajko AB, Geller DA, Gamblin TC. Management of unresectable symptomatic focal nodular hyperplasia with arterial embolization. J Vasc Interv Radiol 2009; 20: 543-7.

  42. Terkivatan T, Hussain SM, Lameris JS, IJzermans JN. Transcatheter arterial embolization as a safe and effective treatment for focal nodular hyperplasia of the liver. Cardiovasc Intervent Radiol 2002; 25: 450-3.

  43. Vogl TJ, Own A, Hammerstingl R, Reichel P, Balzer JO. Transarterial embolization as a therapeutic option for focal nodular hyperplasia in four patients. Eur Radiol 2006; 16: 670-5.

  44. Yoon SS, Charny CK, Fong Y, Jarnagin WR, Schwartz LH, Blumgart LH, DeMatteo RP. Diagnosis, management, and outcome of 115 patients with hepatic hemangiomas. J Am Coll Surg 2003; 197: 392-402.

  45. Couinaud C. Le foie. Etudes anatomiques et chirurgicales. Paris: Masson; 1957.

  46. Dindo D, Demartines N, Clavien PA. Classification of surgical complications: a new proposal with evaluation in a cohort of 6336 patients and results of a survey. Ann Surg 2004; 240: 205-13.

  47. Koea JB, Yeong ML. Focal nodular hyperplasis and hepatocellular carcinoma: uncommon companios? Pathology 2014; 46: 348-50.

  48. Croome KP, Yamashita MH. Laparoscopic vs open hepatic resection for benign and malignant tumors: An updated meta-analysis. Arch Surg 2010; 145: 1109-18.

  49. Reddy SK, Tsung A, Geller DA. Laparoscopic liver resection. World J Surg 2011; 35: 1478-86.

  50. Croner RS, Perrakis A, Brunner M, Matzel KE, Hohenberger W. Pioneering robotic liver surgery in Germany: first experiences with liver malignancies. Front Surg 2015; 2: 18.




2020     |     www.medigraphic.com